Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Courtney Vito"'
Autor:
Joyce C. Niland, Veronica Jones, Lesley Taylor, X Wang, Lily L. Lai, L Springer, Laura Kruper, Rebecca A. Ottesen, J Nikowitz, Z Bostanci, Isaac Benjamin Paz, John H. Yim, Courtney Vito
Publikováno v:
Cancer Research. 78:P5-22
Nipple-areola sparing mastectomy (NSM) may be offered to some women with breast cancer as an alternative to skin sparing (SSM) or total mastectomy (TM) with excellent cosmetic results and acceptable recurrence risk. The aim of this study is to determ
Autor:
Joanne E. Mortimer, Karineh Petrossian, Noriko Kanaya, Daniel Schmolze, Pei Yin Hsu, Hannah Lu, Duc Nguyen, Shiuan Chen, Laura Kruper, Peiguo Chu, Victoria Shang Wu, Chunyu Liu, Courtney Vito, Hang Kai Hsu, Masaya Kai
Publikováno v:
Clinical Cancer Research. 24:395-406
Purpose: Therapeutic strategies against hormonal receptor–positive (HR+)/HER2+ breast cancers with poor response to trastuzumab need to be optimized. Experimental Design: Two HR+/HER2+ patient-derived xenograft (PDX) models named as COH-SC1 and COH
Autor:
Victoria L. Seewaldt, Christine Thai, Terry Hyslop, Kendall J. Kennedy, Alan Nunez, Ombeni M. Idassi, Carola M. Zalles, Ellen J. Rippberger, Karen Harold, Laura Kruper, Margarita Robles, Angelica Sanchez, Amy C. Polverini, Angela K. Wong, Jackelyn A. Alva-Ornelas, Courtney Vito, Tanya A. Chavez, Christopher Sistrunk, Noe R. Chavez, Sharon Clancy, Krista M. Round, Daniel Schmolze, Jerneja Tomsic, Chidimma M.K. Kalu, Veronica Jones
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:A082-A082
The United States is increasingly racially and ethnically diverse. In fact, California is now a majority-minority region, with a greater percentage of its population comprised of racial minorities than whites. Yet, minorities are continually under-re
Autor:
Chidimma M.K. Kalu, Angela K. Wong, Jackelyn A. Alva-Ornelas, Karen Herold, Ombeni M. Idassi, Ellen J. Rippberger, Christine Thai, Tanya A. Chavez, Veronica Jones, Victoria L. Seewaldt, Krista M. Round, Christopher Sistrunk, Jerneja Tomsic, Lisa D. Yee, Sharon Clancy, Margarita Robles, Amy C. Polverini, Courtney Vito, Noe R. Chavez, Angelica Sanchez, Kendall J. Kennedy, Laura Kruper, Alan Nunez, Stacey N. Doan
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:A084-A084
The United States (US) is racially and culturally diverse. Still, white women disproportionately comprise clinical trial participants, stemming largely from the fact that minorities often decline participation. Clinical trial findings, therefore, hav
Autor:
Alan Nunez, Victoria L. Seewaldt, Jackelyn A. Alva-Ornelas, Tanya A. Chavez, Sharon Clancy, Krista M. Round, Angela K. Wong, Karen Herold, Ombeni M. Idassi, Terry Hyslop, Lisa D. Yee, Ellen J. Rippberger, Courtney Vito, Daniel Schmolze, Chidimma M.K. Kalu, Noe R. Chavez, Angelica Sanchez, Kendall J. Kennedy, Veronica Jones, Margarita Robles, Jerneja Tomsic, Christopher Sistrunk, Christine Thai, Laura Kruper, Amy C. Polverini
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:B109-B109
Purpose: To highlight the importance of building a high-risk breast cancer clinic for women who do not have a BRCA 1, BRCA 2 or other highly penetrant cancer susceptibility mutation. Background: Breast cancer is the most common cancer in women and th
Autor:
Joanne E. Mortimer, Tommy Tong, Christina Yeon, James Waisman, A Huria, John H. Yim, George Somlo, Paul Frankel, Lesley Taylor, Veronica Jones, C Gaal, Benjamin Paz, Lusine Tumyan, Courtney Vito, Laura Kruper, Daneng Li, Y Yuan
Publikováno v:
Cancer Research. 77:P4-21
Background: Pathologic complete response (pCR) to HER2-targeting neoadjuvant therapy (NT) predicts for improved survival (Cortazar et al, Lancet, 2014). The addition of pertuzumab to trastuzumab and docetaxel increased pCR rates, and, as first line t
Autor:
Joanne E. Mortimer, Masaya Kai, Courtney Vito, Shang Victoria Wu, Shiuan Chen, Thenhang Luu, Noriko Kanaya, Hannah Lu, Laura Kruper
Publikováno v:
Cancer Research. 75:P6-11
Background: Up to 10% of total breast cancers are positive for both hormone receptor [HR: estrogen receptor (ER) and/or progesterone receptor (PR)] and HER2. These patients belong mainly to the luminal B subtype, which exhibits resistance to endocrin
Autor:
Emily Marcinkowski, Laura Kruper, Joanne E. Mortimer, Amy C. Polverini, Courtney Vito, Rebecca A. Nelson, Lesley Taylor, Lily L. Lai, John H. Yim, Veronica Jones
Publikováno v:
Annals of Surgical Oncology. 23:3392-3402
To optimize breast cancer care, several organizations have crafted guidelines to define best practices for treating breast cancer. In addition to recommended therapies, 'timeliness of treatment' has been proposed as a quality metric. Our study evalua
Autor:
Joanne E. Mortimer, Arti Hurria, Lesley Taylor, S. Koehler, Tommy Tong, Courtney Vito, Kim Robinson, Y Yuan, George Somlo, James Waisman, Samuel Chung, John H. Yim, Benjamin Paz, Laura Kruper, Christina Yeon, Paul Frankel
Publikováno v:
Cancer Research. 76:P1-14
Background: Pathologic complete response (pCR) and residual cancer burden (RCB scores of 0 [pCR] or 1[near CR]) after neoadjuvant chemotherapy (NCT) may predict for improved survival (Symmans et al. J Clin Oncol 25:4414-22, 2007). We set out to test
Autor:
Victoria L. Seewaldt, Chidimma M.K. Kalu, Courtney Vito, Lisa D. Yee, Krista M. Round, Karen Herold, Tanya A. Chavez, Ombeni M. Idassi, Angela K. Wong, Christopher Sistrunk, Ellen J. Rippberger, Noe R. Chavez, Alan Nunez, Angelica Sanchez, Terry Hyslop, Kendall J. Kennedy, Amy C. Polverini, Margarita Robles, Christine Thai, Jackelyn A. Alva-Ornelas, Sharon Clancy, Jerneja Tomsic, Carola M. Zalles, Laura Kruper, Veronica Jones
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:A083-A083
Background: Breast cancer (BC) prevention clinical trials (CTs) play a vital role in the progress of preventative measures and treatments for all races and ethnicities. However, Northern European whites (NE/W) continue to be disproportionally enrolle